Transcutaneous Carbon Dioxide Treatment Is Capable of Reducing Peripheral Vascular Resistance in Hypertensive Patients

Balázs Németh, István Kiss, Bella Ajtay, Iván Péter, Zita Kreska, Attila Cziráki, I. Horváth, Zénó Ajtay

Research output: Contribution to journalArticle

Abstract

AIM: We aimed to investigate the effects of a single carbon dioxide (CO2) treatment on arterial stiffness by monitoring the changes of aortic pulse-wave velocity (PWV) and aortic augmentation index (AIXao), which are indicators of arterial stiffness.

PATIENTS AND METHODS: PWV and AIXao were measured by an invasively validated oscillometric device. The measurements of stiffness parameters were performed before the CO2 treatment, and at 1, 4 and 8 h after the first treatment.

RESULTS: Thirty-one patients were included. No significant changes were found in PWV. AIXao decreased significantly 1 h and 4 h after CO2 treatment compared to baseline values (p=0.034 and p<0.001). AIXao increased 8 h after the CO2 treatment, but remained significantly lower than baseline AIXao values (p=0.016).

CONCLUSION: CO2 treatment is capable of reducing peripheral vascular resistance. We hypothesize that CO2 is not only a temporal vasodilator but is also capable of activating vasodilation pathways.

Original languageEnglish
Pages (from-to)1555-1559
Number of pages5
JournalIn vivo (Athens, Greece)
Volume32
Issue number6
DOIs
Publication statusPublished - Nov 1 2018

    Fingerprint

Keywords

  • aortic augmentation index
  • aortic pulse-wave velocity
  • aortic stiffness
  • Carbon dioxide therapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this